Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - STOCK-BASED COMPENSATION
Stock-based Compensation AVTX - Avalo Therapeutics, Inc.
3.48 M
LAST VALUE
-34.77%
2 YEAR CAGR
7.42%
5 YEAR CAGR
16.60%
10 YEAR CAGR